文献速递艾滋病与性传播感染

线粒体单倍群与HIV感染者及非感染者的左心室舒张功能障碍

Mitochondrial Haplogroups and Left Ventricular Diastolic Dysfunction in People Living With and Without HIV.
PubMed 文献 · J Infect Dis · 2026-01-01

本研究基于多中心AIDS队列研究和女性跨机构HIV研究,纳入842名男性和898名女性,探讨线粒体DNA单倍群及D类药物与左心室舒张功能障碍(LVDD)的关联。结果显示,在HIV感染男性中,欧洲单倍群H与LVDD风险降低相关(OR 0.50),JT分支与风险增加相关(OR 2.09),D类药物暴露与风险增加相关(OR 1.94);女性中未发现显著关联,但HIV血清状态修饰了L2和L3单倍群的关联。

要点

  • HIV感染男性中,线粒体单倍群H与LVDD风险降低相关,JT分支与风险增加相关。
  • HIV感染男性中,D类药物暴露与LVDD风险增加相关(OR 1.94)。
  • 女性中未发现单倍群与LVDD的显著关联,但HIV状态修饰L2和L3的关联。

核心结论

  • 线粒体遗传变异和D类药物使用与HIV感染男性的LVDD风险改变相关,提示潜在生物学机制可用于监测或治疗策略。

研究设计与样本

  • 研究纳入来自多中心AIDS队列研究和女性跨机构HIV研究的个体,共842名男性(455名HIV感染者,387名非感染者)和898名女性(620名HIV感染者,278名非感染者),使用超声心动图评估LVDD,通过HaploGrep推断mtDNA单倍群,采用探索性多变量逻辑回归分析。

主要发现

  • 在非西班牙裔白人HIV感染男性中,欧洲单倍群H与LVDD风险降低相关(OR 0.50;95% CI 0.26-0.93),JT分支与风险增加相关(OR 2.09;95% CI 1.00-4.36)。
  • 在HIV感染男性中,D类药物暴露与LVDD风险增加相关(OR 1.94;95% CI 1.21-3.13)。
  • 在女性中,未观察到单倍群与LVDD的显著关联,但HIV血清状态修饰了单倍群L2(交互作用P=0.036)和L3(交互作用P=0.045)与LVDD的关联。
  • LVDD患病率在女性中为29%,在男性中为24%。

关键数值与推荐

  • LVDD定义采用抗逆转录病毒治疗条件下心脏功能特征标准。
  • 非洲单倍群包括L0L1、L2、L3或「其他」,欧洲单倍群包括UK、H、JT或「其他」。

临床怎么用

  • 对于HIV感染男性,尤其携带欧洲单倍群JT或暴露于D类药物者,可考虑加强LVDD监测。
  • 线粒体单倍群分型可能有助于识别LVDD高风险HIV感染者,但需进一步验证。

局限性

  • 研究未对多重比较进行调整。
  • 探索性分析,结果需在独立人群中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac dysfunction is more common in people with HIV (PWH) than those without HIV (PWoH), with mitochondrial dysfunction implicated in pathogenesis. We investigated whether variations in mitochondrial DNA (mtDNA) and certain dideoxynucleoside analogs (D-drugs) relate to left ventricular diastolic dysfunction (LVDD) in PWH. METHODS: We included individuals with echocardiograms from the Multicenter AIDS Cohort Study and Women's Interagency HIV Study. LVDD was defined using characterizing heart function on antiretroviral therapy criteria. mtDNA haplogroups were inferred using HaploGrep. Separate exploratory multivariable logistic regressions examined associations between LVDD and African (L0L1, L2, L3, or "other") or European haplogroups (UK, H, JT, or "other"), D-drugs, and their interactions. No adjustments were made for multiple comparisons. RESULTS: Among 842 men (455 PWH and 387 PWoH) and 898 women (620 PWH and 278 PWoH), LVDD prevalence was 29% in women and 24% in men. Among non-Hispanic White men with HIV, European haplogroup H was associated with lower odds of LVDD (odds ratio [OR], 0.50; 95% CI, 0.26-0.93), while haplogroup clade JT was associated with increased odds (OR, 2.09; 95% CI, 1.00-4.36). In men with HIV, D-drug exposure was associated with increased odds of LVDD (OR, 1.94; 95% CI, 1.21-3.13). No significant associations were observed between haplogroups and LVDD in women. HIV serostatus modified the association of haplogroup L2 (pinteraction = 0.036) and L3 (pinteraction = 0.045) with LVDD in women. CONCLUSIONS: Mitochondrial genetic variation and D-drug use were associated with altered LVDD risk in men with HIV, highlighting potential biological mechanisms that may be targeted for surveillance or therapeutic strategies.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Cronin C, Sun J, Kizer JR, et al. Mitochondrial Haplogroups and Left Ventricular Diastolic Dysfunction in People Living With and Without HIV. J Infect Dis. 2026. PMID: 41677801. doi:10.1093/infdis/jiag090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。